Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of 5% VVN001 Ophthalmic Solution in Dry Eye Disease
Sponsor: VivaVision Biotech, Inc
Summary
This is a Phase 3, randomized, double-Masked, vehicle-controlled, multi-center study designed to evaluate the safety and efficacy of 5% VVN001 Ophthalmic Solution versus vehicle in Chinese subjects with dry eye disease.
Official title: A Phase 3, Randomized, Double-Masked, Vehicle-controlled, Multi-center Study Evaluating the Safety and Efficacy of 5% VVN001 in Chinese Subjects With Dry Eye Disease
Key Details
Gender
All
Age Range
30 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
700
Start Date
2024-04-01
Completion Date
2026-03-31
Last Updated
2024-11-20
Healthy Volunteers
No
Conditions
Interventions
VVN001 Ophthalmic Solution, 5%
VVN001 Ophthalmic Solution, 5%
VVN001 Ophthalmic Solution, Vehicle
VVN001 Ophthalmic Solution, Vehicle
Locations (1)
Eye & Ent Hospital of Fudan University
Shanghai, Shanghai Municipality, China